Different 5-hydroxytryptarnine (5-HT) receptor subtypes mediate different behavioural responses. Compounds acting at more than one 5-HT receptor exert behavioural effects which may be the result of response competition or a specific interaction between pathways within the CNS. Therefore the mutual interaction between different 5-HT receptor subtypes was studied.
INTRODUCTION
and later Grahame-Smith (1971) described the 5-hydroxytryptamine (5-HT) syndrome, consisting of forepaw treading, head weaving, flat body posture, head shakes, hind limb abduction and tremors, following injections of 5-hydroxytryptophan plus a monoamine oxidase inhibitor, this syndrome and elements of it have been seen after injection of a variety of 5-HT receptor agonists. The synthesis of 5-HT receptor subtype-selective agonists andlor antagonists has made it possible to study the functions of the different 5-HT receptors, and to ascribe some components of the 5-HT syndrome to selective activation of one of these 5-HT receptor subtypes.
At present there is evidence to suggest that drug-induced head shakes are the result of 5-HT2 receptor activation (Yap and Taylor, 1983) and that stimulation of the presynaptic 5-HTIA receptor results in hypothermia (Gudelsky et al., 1986; . Activation of the post-synaptic 5-HTIA receptor induces forepaw treading (Tricklebank et al., 1984) . Recently, we suggested that selective activation of the 5-HTIA receptors, possibly presynaptic, induces lower lip retraction and that the induction of penile erections is the result of 5-HTlc receptor activation (Berendsen et al., 1989a (Berendsen et al., , 1990 .
However, compounds with activity at more than one subtype of 5-HT receptor do not always induce the behaviour thought to be the result of activation of those receptors. For example, the compound RU 24969, (5 methoxy-3(1,2,3,6-tetra hydropiridin-4-yl) 1H indole) which binds to 5-HTIA and 5-HTIB receptors (Hoyer, 1988a) only induces the 5-HTlA related lower lip retraction. 5-Methoxy-N,N-dimethyl tryptarnine (5-MeODMT), a compound that binds with high affinity to 5-HTIA, 5-HTIC and, with lower affinity to the 5-HT2 receptor (Hoyer 1988b; Titeler et al., 1988) only induces lower lip retraction after blockade of the 5-HTlc receptors (Berendsen et al., 1989a) . (+)-1-(2,5 dimethoxy-4-iodophenyl-2-aminopropane HC1 (DOI), which binds to both 5-HT2 and 5-FITlC receptors (Hoyer, 1988b; Titeler et al., 1988) , induces the 5-HT2-related head shakes, but not the 5-HTlc-related penile erections. However, in rats pretreated with a 5-HT2 antagonist, this compound induces penile erections while the head shakes disappear. It has also been shown that the potency to induce penile erections by compounds that have affinity for 5-HTIC and 5-HT2 receptors, is dependent on their 5-HTlc/5-HT2 affinity ratio (Berendsen et al., 1990) . All this points to a functional interaction between the different receptor subtype-induced behaviours, in such a way that induction of a particular behaviour by activation of a certain receptor subtype can prevent or mask the behaviour induced by activation of another 5-HT receptor subtype. Functional interactions in the penile erection test (5-HTlc receptorinduced) and in the lower lip retraction test (5-HTlA receptor-induced) have been described before (Berendsen et al., 1989a (Berendsen et al., , 1990 . We have now studied more systematically how activation of one 5-HT receptor subtype influences the expression of the behaviour induced by activation of another.
In this study, we have measured the 5-HTIA receptor-mediated forepaw treading and the 5-HT2 receptor-mediated head shake response in rats. Locomotor activity and body temperature in mice were included to show that the functional interactions of 5-HT receptor subtypes also takes place in this species.
MATERIALS AND METHODS

Animals
Mice: NaYve male mice (Crl: CD-l(ICR)BR, from Charles River, Germany) weighing 24-26 g were used. The mice were housed in macrolon cages (40 x 23 x 15 cm) 20 animals per cage, under a controlled 12 h light-dark cycle (light on 06.00 h) and were allowed free access to standard food pellets and tap water. m: Ndive male Wistar rats (Cpb:WU, Harlan Sprague Dawley, Zeist, The Netherlands) weighing 200-250 g were used. The animals were housed in white PVC cages (40 x 40 x 18 cm) with a wire mesh lid, five animals per cage, under controlled 12 h light-dark cycle (lights on 06.00 h) and were allowed free access to standard food pellets and tap water.
Procedures
Locomotor activitv in mice: The locomotor activity of the mice was measured in 20 small photocell cages (11 x 11 x 16 cm) (four rows of 5 connected cages). The lid and both side walls of the cages were made of grey PVC, the front and back walls of clear perspex and the base was made of a stainless steel grid floor. Each cage was supplied with 8 infra-red light beams connected to a counter for recording the light beam interruptions.
Tests were done in blocks, consisting of 20 mice, with treatments randomized between all animals within the experiment. At least 10 animals per treatment were used. Immediately following administration of the compounds the mice were placed individually in the activity cages and the number of light beam interruptions was measured for 30 rnin.
& x & temperature in mice:
The hypothermia tests were performed and replicated 3 times, each consisted of 3 mice from each treatment group. Within a block the various treatments were randomized between the cages, mice receiving the same treatment were placed within one cage. Ten minutes after treatment with a compound the rectal temperature of the mice was measured with an electrothermometer (Ellab TE3, Electrolaboriet, Copenhagen, Denmark). The lubricated probe was inserted about 2.5 cm. 8-OH-DPAT (0.25 mgtkg), or placebo was then injected immediately and 10,20,30 and 40 min later rectal temperature was measured again. The room temperature was 21
Foreuaw treading: Forepaw treading in rats was also measured three times. Within each block all treatments were randomized between animals. After the animals had been heated with the compound to be investigated, immediately followed by an injection of 8-OH-DPAT (0.22 mgkg), the rats were placed in small observation cages (7.5 x 18 x 30 cm) and forepaw treading was measured from 15 to 30 min after treatment by scoring the presence or absence of forepaw treading every 30 s. By use of this time sampling method a maximal score of 31 could be reached. Eight rats per treatment group were used.
Head shakes: The head shake tests were run with blocks of eight animals, with --each treatment present at least once in every block. Head shakes in rats were induced by DO1 (0.22 mgkg). Immediately after treatment with DO1 and the agonist under study the rats were placed in small observation cages (7.5 x 18 x 30 cm) and the number of head shakes was counted during 30 min.
Drugs and solutions
The following drugs were used: 2 chloro-6-(1-piperazinyl) pyrazine monohydrochloride (MK 212 . All compounds were dissolved in sterile saline solution and solutions were freshly prepared. Injections were made subcutaneously into the loose skin at the back of the neck. In rats a dose volume of 5 ml per kg body weight was used and in mice this dose volume was 10 ml per kg body weight. Control animals were injected with an equivalent volume of vehicle.
Statistics
Locomotor activity test: The total test period of 30 min was divided into 3 periods of 10 min each. The results of the first 10 min period are presented as mean photocell interruptions + S.E.M. Statistical comparisons were made by the Mann-Whitney U test.
Hwothermia m: The temperature changes are given in degrees centigrade compared to control groups and expressed as means per treatment group + S.E.M.
Statistical comparisons were made by use of an analysis of variance for a completely randomized design.
Forepaw treading and head shakes tests: The results are expressed as the mean number of scores + S.E.M. Statistical comparisons were made by comparing the results of each group with the results of the control group using the Mann-Whitney U test.
RESULTS
Locomotor activity in mice
Locomotor activity in mice was measured for 30 min which was divided into periods of 10 min each. The activity score of the placebo-treated mice was highest during the first 10 min and decreased during the following 10 min periods. Suppression of locomotor activity by 8-OH-DPAT (0.5 mglkg) was strong and highly significantly during the first 10 min. In the next two 10 rnin periods this effect weakened. In the third period the effect was no longer different from placebo ( fig. 1) . For the interaction studies of 8-OH-DPAT with other agonists only the first 10 min periods are presented ( fig. 2 ).
When given alone the compounds DO1 (0.046 -0.22 mgkg) and TFMPP (0.22 -1.0 mgkg) did not significantly change activity in any of the 3 periods. In the third period these compounds tended to increase locomotor activity, but this effect was never significant. The lowest and highest doses of mCPP (0.22 and 1.0 mgkg) and MK 212 (0.22 and 1.0 mgkg) significantly inhibited locomotor activity of the mice but only in the first 10 min period. CGS 12066B (2.2 and 10 mgkg) significantly inhibited the locomotor activity in the same period. But in the second and third period there was no difference compared with placebo.
When combined treatments were given, DO1 partly attenuated the 8-OH-DPATinduced hypoactivity in the first 10 min. In the second period the activity of the animals, given the combined treatment, was no longer significantly different from the placebo group and in the third period their activity was significantly higher than that of the placebo group. TFMPP and mCPP at all doses tested markedly attenuated 8-OH-DPATinduced hypoactivity. In the third period the activity of the combined treatment groups was significantly higher than that of the control groups. MK 212 attenuated 8-OH-DPAT-induced hypoactivity in the first and second period. In the third period no significant differences existed between the groups. Only a dose of 10 mgkg CGS 12066B slightly attenuated 8-OH-DPAT-induced hypoactivity in the first 10 rnin period.
Body temperature in mice
8-OH-DPAT (0.25 mgkg), consistently induced a hypothermic response which was maximal at 10 min after treatment. Therefore in Figure 3 the responses at this time point only are given. DOI, TFMPP, mCPP, and MK 212 all dose dependently attenuated 8-OH-DPAT-induced hypothermia. When given alone, none of these compounds significantly changed the bodytemperature compared with the placebo groups. CGS 12066B at 10 mgkg induced a weak but not significant hypothermia by itself. Given in combination with 8-OH-DPAT this compound at 10 mgkg potentiated 8-OH-DPATinduced hypothermia significantly.
Forepaw treading in rats
8-OH-DPAT (0.22 mgkg) induced forepaw treading with a mean score varying from 13.5 to 19.5 (maximal possible score is 31) (fig. 4 ). Forepaw treading induced by 8-OH-DPAT was dose dependently potentiated by DO1 (ED150 = 0.08 mgkg). TFMPP, at lower doses potentiated and at higher doses inhibited forepaw treading. mCPP and and 5-HTlc sites but induces 5-HT2-mediated behaviours. This indicates that for a mixed 5-HTlc/5-HT2 agonist the behaviour related to activation of the 5-HT2 receptor prevails over the behaviour induced by 5-HTlc receptor activation. The head shake response induced by DOI, could be attenuated by 8-OH-DPAT, TFMPP, mCPP and MK 212 suggesting that activation of both 5-HTlA and 5-HTlc receptors functionally inhibits this 5-HT2-mediated response.
Functional interactions between the different 5-HT receptor subtype-mediated effects does not seem to be restricted to the behavioural expression of activation of these receptors. It has been shown that mCPP and TFMPP inhibit 5-HT2 receptor-mediated vascular contractions (Cohen and Fuller, 1983) and that mCPP antagonizes cortical 5-HT2 receptors that are linked to phosphoinositide turnover (Conn and Sanders-Bush, 1987) . Moreover, it was shown in electrophysiological experiments that 5-HTIA and 5-HTlB/5-HTIC agonists have different effects on neuronal cell firing in different brain regions (Sprouse and Aghajanian, 1988) . Opposite effects of 5-HTlA and non-5-HTlA (5-HTIB or 5-HTlc) receptor activation have been found in several experiments. For example, in the startle response in rats (Davis et al., 1986) , in aversive responding seen after electrical stimulation of the periaqueductal grey and in several models of animal anxiety .
The observed functional interactions of 5-HT receptor-subtype mediated effects may occur at different levels, such as a molecular allosteric mutual influence, opposing effects on second messengers or more broadly via presynaptic-postsynaptic locations or functional influences from different brain structures.
The data emphasize the difficulty of drawing conclusions from functional measurements when the compounds that are being investigated have mixed receptor affinities and efficacies. The availability of selective antagonists for the different 5-HT receptor subtypes would greatly facilitate the interpretation of such data. from Schoeffter and Hoyer (1989) 5, The 5-HTIc preference ratio represents the ratio of dissociation constants for 5-HT2 and 5-HTlc receptors. Dissociation corlstants were the antilogs of the pKd values as given in the table. 
induced 0 = no effect; -= inhibition; + = potentiation; (-) = inhibition only at a high dose; (+) = potentiation only at a high dose; Berendsen et al. (1989a) ; b, Berendsen et al. (1990) .
both activation of 5-HTlc and/or 5-HT2 receptors can functionally inhibit these 5-HTIA-induced effects. The mixed 5-HTlAIIB agonist CGS 12066B (Neale et al., 1987; Schoeffter and Hoyer 1989 ) had no effect on 8-OH-DPAT-induced hypolocomotion. However, hypothermia induced by 8-OH-DPAT was potentiated by a high dose of CGS 12066B. Previously, we demonstrated that lower lip retraction induced by 8-OH-DPAT is not influenced by CGS 12066B, whereas activation of 5-HTlc and/or 5-HT2 receptors attenuated this effect (Berendsen et al., 1989a) . This might point to a lack of interaction between the 5-HTlA and 5-HTIB receptor-induced hehaviours. It is also possible that the penetration of CGS 12066B into the brain is poor. A lack of interaction with the 5-HTIA and 5-HTIB receptors might also be inferred from the ability of the mixed 5-HTlA/5-HTlB agonist RU 24969 to induce the 5-HTlArelated lower lip retraction (Berendsen et al., 1989a) . One might argue that the increased locomotor activity after DOI, TFMPP and mCPP contributes to the attenuation of 8-OH-DPAT-induced hypothennia. However, the effect of these compounds on hypothermia was strongest after 10 min whereas the increase in locomotor activity occurred no earlier than 20 -30 min after treatment. The forepaw treading induced by 8-OH-DPAT was influenced differently by the agonists: DO1 dose-dependently potentiated the response while TFMPP potentiated it at low doses but attenuated it at higher doses. mCPP and MK 212 both attenuated forepaw treading. These compounds bind to 5-HTlc and 5-HT2 sites, but if the selectivity-ratio of these compound for the 5-HTlc over 5-HT2 receptors is calculated the sequence is MK 212 > mCPP > TFMPP > DO1 (table 1) . It thus seems that as the preference for 5-HTlc receptors over 5-HT2
receptors decreases the effect on forepaw treading changes from an inhibition to a potentiation. We have seen the same order of potency with these compounds for their ability to induce penile erections (Berendsen et al., 1990) . The potentiating effect of DO1 and TFMPP on forepaw treading confirms previous findings (Berendsen et al. 1989b; Arnt and Hyttel 1989) . Among the symptoms induced by 8-OH-DPAT, hypothermia and lower lip retraction are thought to be presynaptically-mediated (Goodwin et al., 1987; Wozniak et al., 1988; Berendsen et al., 1989a ) whereas forepaw treading is thought to be a postsynaptically-mediated effect (Tricklebank et al., 1985) . The data thus suggest that presynaptically-induced 5-HTIA effects are attenuated by both 5-HTlc and 5-HT2 receptor activation, whereas postsynaptically-mediated 5-HTIA effects are potentiated by concomitant activation of 5-HT2 and attenuated by concomitant activation of 5-HTlc receptors. Injection of CGS 12066B did not change the 8-OH-DPAT-induced hypoactivity or forepaw treading response. Therefore, there is no evidence as yet to suggest an influence of 5-HTIB receptor activation on 5-HTIA receptor-mediated effects. The functional effect of 5-HTIA, 5-HTIB and 5-HT2 receptor activation on a 5-HTlc receptor-mediated effect has been discussed before (Berendsen et al., 1990) . It has been shown that activation of the 5-HTIA receptor attenuated the 5-HTlc-mediated induction of penile erections (PE) and that induction of PE by mixed 5-HTlc/5-HT2 agonists depends on the selectivity of these compounds for 5-HTlc over 5-HT2 receptors. This suggests that activation of the 5-HT2 receptor inhibits or prevents expression of 5-HTlc receptor-mediated PE. DO1 binds with similar affinity to 5-HT2 MK 212 dose-dependently inhibited forepaw treading (ID50 = 1 mgkg for mCPP). However MK 212 had less inhibitory activity than mCPP, at 2.2 mgkg the inhibition was 43%. CGS 12066B had no effect.
Head shakes in rats
The results of these experiments are given in fig. 5 . Head shakes induced by DO1 (0.22 mg/kg) were dose-dependently inhibited by 8-OH-DPAT, mCPP, TFMP and MK 212. Their ID50 values were 0.03; 0.1; 0.7 and 2 mgkg respectively. CGS 12066B significantly inhibited DOI-induced head shakes only at the highest dose tested (10 mgkg).
DISCUSSION
The main finding of the present experiments was that behavioural responses elicited by various 5-HT receptor subtypes can be modified by co-activation of other 5-HT receptor subtypes. A key element in interpreting these findings is the affinities of each agonist for the different receptor subtypes. These are summarised in Table 1. The  table also contains the selectivity-ratios of these compounds for 5-HTIC over 5-HT2 receptors. These data show that very selective agonists or antagonists for these receptors do not exist. We realize that the lack of selectivity of these compounds for the 5-HT receptor subtypes seriously hinders the interpretation of the data obtained in the present study. Also, binding data, on which we have to rely extensively, do not distinguish agonist and antagonist properties of the compounds. Nevertheless, our data require a tentative interpretation in order to provide a working hypothesis for future experiments. Furthermore, the interactions that we have observed should be taken into account when interpreting behavioural changes induced by drugs acting on 5-HT receptors. The proposed interactions between the 5-HT receptor subtype responses are summarized in Table 2 .
The effect of 8-OH-DPAT on locomotor activity in rats is controversial, increased locomotor activity was found by Tricklebank et al. (1984) and Broekkarnp et al. (1989) whereas Hillegaart et al. (1989) found decreased activity. In mice we found a hypoactivity, at least during the first 20 min, after treatment with 0.5 mgkg. The hypothermic effect of 8-OH-DPAT in mice is consistent with other studies in mice and rats Hjorth 1985; Goodwin et al. 1987) . In contrast to our results in mice, TFMP, mCPP and MK 212 have been shown to induce hyperthermia in rats (Maj and Lewandowska 1980; Yarnawaki et al. 1983; Pawlowski 1984; Gudelski 1986) . These authors however gave a higher dose of the compounds andor did the experiments in heat adapted rats. Both 8-OH-DPAT-induced hypoactivity and hypothermia in mice could be attenuated by DOT, TFMPP, mCPP and MK 212. These compounds bind preferentially to the 5-HTlc andor 5-HT2 receptors, suggesting that
